Connect with us
Eli Lilly warns that compounded tirzepatide mixed with vitamin B12 may form harmful impurities with unknown health effects. These untested combinations lack safety data and regulatory...
In 2025, JAMA highlighted studies shaping medical practice, notably showing GLP-1 drugs cut hospitalization or death in heart failure patients by over 40%, and that shingles...
Giftify [NASDAQ: GIFT] is disrupting the GLP-1 market with a smart savings model providing consumers with discounted Ozempic and Wegovy. With the FDA closing the loophole...